Automated multiclass segmentation, quantification, and visualization of the diseased aorta on hybrid PET/CT-SEQUOIA.

Autor: van Praagh GD; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Nienhuis PH; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Reijrink M; Department of Internal Medicine, division of Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Davidse MEJ; Department of Applied Mathematics and Technical Medicine Center, University of Twente, Enschede, the Netherlands., Duff LM; Faculty of Engineering and Physical Sciences, University of Leeds, Leeds, UK., Spottiswoode BS; Siemens Medical Solutions USA, Inc., Knoxville, Tennessee, USA., Mulder DJ; Department of Internal Medicine, division of Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Prakken NHJ; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Scarsbrook AF; University of Leeds, School of Medicine, Leeds, UK.; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; NIHR Leeds Medtech and In vitro Diagnostics Co-operative, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Morgan AW; University of Leeds, School of Medicine, Leeds, UK.; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; NIHR Leeds Medtech and In vitro Diagnostics Co-operative, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Tsoumpas C; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Faculty of Engineering and Physical Sciences, University of Leeds, Leeds, UK., Wolterink JM; Department of Applied Mathematics and Technical Medicine Center, University of Twente, Enschede, the Netherlands., Mouridsen KB; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark., Borra RJH; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Diagnostic Radiology, Turku University Hospital, Turku, Finland., Sinha B; Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Slart RHJA; Medical Imaging Center, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Biomedical Photonic Imaging, University of Twente, Enschede, the Netherlands.

Publikováno v: Medical physics [Med Phys] 2024 Jun; Vol. 51 (6), pp. 4297-4310. Date of Electronic Publication: 2024 Feb 07.

Updated practice guideline for dual-energy X-ray absorptiometry (DXA).

Autor: Slart RHJA; Medical Imaging Centre, Department of Nuclear Medicine & Molecular Imaging (EB50), University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO 9700 RB, Groningen, The Netherlands. r.h.j.a.slart@umcg.nl., Punda M; Department of Oncology and Nuclear Medicine, University Hospital Centre Sestre Milosrdnice, Vinogradska 29, Zagreb, Croatia., Ali DS; Department of Endocrinology, McMaster University, Hamilton, L8S 4L8, Canada., Bazzocchi A; Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Via G. C. Pupilli 1, Bologna, 40136, Italy., Bock O; Department of Osteoporosis, Inselspital, Bern University Hospital, Switzerland, IG Osteoporose, Bern, Switzerland., Camacho P; Loyola University Medical Center (LUMC), 2160 S 1st Ave, Maywood, IL, 60153, USA., Carey JJ; University of Galway, Galway, H91 V4AY, Ireland., Colquhoun A; Centre for Osteoporosis & Bone Health, Women's College Hospital, Toronto, ON, Canada., Compston J; Cambridge Biomedical Centre, Cambridge, UK., Engelke K; Department of Medicine, Institute of Medical Physics, FAU University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Ulmenweg 18, 91054, Erlangen, Germany., Erba PA; Department of Medicine and Surgery, Nuclear Medicine Unit, ASST Ospedale Papa Giovanni, University of Milan-Bicocca, Piazza, Bergamo, Italy., Harvey NC; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital NHS Foundation Trust, Southampton, UK., Krueger D; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Lems WF; Department of Rheumatology, Amsterdam University Medical, Center, The Netherlands., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, 87106, USA., Morgan S; The UAB Osteoporosis Prevention and Treatment Clinic, The University of Alabama at Birmingham, Birmingham, Al, USA., Moseley KF; Division of Endocrinology, Johns Hopkins University, Baltimore, MD, 21201, USA., O'Brien C; Brant Community Healthcare System, Brantford, ON, Canada., Probyn L; Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave., Toronto, ON, M4N 3M5, Canada., Rhee Y; Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea., Richmond B; Diagnostic Radiology, Cleveland Clinic Main Campus, 9500 Euclid Avenue, Cleveland, OH, 44195, USA., Schousboe JT; Park Nicollet Clinic and HealthPartners Institute, Minneapolis, MN, USA., Shuhart C; Swedish Bone Health and Osteoporosis Center, 1600 E Jefferson St Ste 300, Seattle, WA, 98122, USA., Ward KA; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Southampton, UK., Van den Wyngaert T; Department of Nuclear Medicine, Antwerp University Hospital, Antwerp, Belgium., Zhang-Yin J; Department of Nuclear Medicine, Clinique Sud Luxembourg, Vivalia, B-6700, Arlon, Belgium., Khan AA; Department of Endocrinology, McMaster University, Hamilton, L8S 4L8, Canada.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.

Cardiovascular PET imaging of fibroblast activation A review of the current literature.

Autor: Loganath K; BHF Centre of Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: kloganat@ed.ac.uk., Craig N; BHF Centre of Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Barton A; BHF Centre of Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Joshi S; BHF Centre of Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Anagnostopoulos C; Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece., Erba PA; Nuclear Medicine, Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy; Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Saraste A; Turku PET Centre, Turku University Hospital and University of Turku, Kiinamllynkatu, Turku, Finland; Heart Center, Turku University Hospital, Turku, Finland., Bucerius J; Department of Nuclear Medicine, Georg-August University Göttingen, University Medicine Göttingen, Göttingen, Germany., Lubberink M; Department of Surgical Sciences/Radiology, Uppsala University, Uppsala, Sweden., Gheysens O; Department of Nuclear Medicine, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Buechel RR; Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland., Habib G; Cardiology Department, APHM, La Timone Hospital, Marseille, France; Aix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France., Gaemperli O; HeartClinic, Hirslanden Hospital Zurich, Hirslanden, Switzerland., Gimelli A; Fondazione Toscana G. Monasterio, Pisa, Italy., Hyafil F; Department of Nuclear Medicine, DMU IMAGINA, Georges-Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, University of Paris, Paris, France; PARCC, INSERM, University of Paris, Paris, France., Newby DE; BHF Centre of Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Slart RHJA; Medical Imaging Centre, Department of Nuclear Medicine & Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Faculty of Science and Technology Biomedical, Photonic Imaging, University of Twente, Enschede, The Netherlands., Dweck MR; BHF Centre of Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2024 Dec 11, pp. 102106. Date of Electronic Publication: 2024 Dec 11.

Calciprotein particle counts associate with vascular remodelling in chronic kidney disease.

Autor: Feenstra L; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Reijrink M; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Internal Medicine, Division of Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Pasch A; Calciscon AG, Biel, Switzerland.; Institute of Physiology and Pathophysiology, Johannes Kepler University Linz, Linz, Austria., Smith ER; Department of Nephrology, Royal Melbourne Hospital, Parkville, Victoria, Australia.; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia., Visser LM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Bulthuis M; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Lodewijk ME; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Mastik MF; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Greuter MJW; Department of Radiology, Medical Imaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Slart RHJA; Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Biomedical Photonic Imaging, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands., Mulder DJ; Department of Internal Medicine, Division of Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Pol RA; Department of Vascular and Transplant Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Te Velde-Keyzer CA; Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Krenning G; Department of Clinical Pharmacy and Pharmacology, Division Experimental Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Hillebrands JL; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2024 Dec 04; Vol. 120 (15), pp. 1953-1966.

[ ^99m Tc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients.

Autor: Tingen HSA; Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. h.s.a.tingen@umcg.nl., Groothof D; Department of Internal Medicine, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Tubben A; Department of Cardiology, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Bijzet J; Department of Laboratory Medicine, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Houwerzijl EJ; Department of Internal Medicine, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Muntinghe FLH; Department of Internal Medicine, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., van der Zwaag PA; Department of Clinical Genetics, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., van der Meer P; Department of Cardiology, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Hazenberg BPC; Department of Rheumatology & Clinical Immunology, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Slart RHJA; Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.; Biomedical Photonic Imaging Group, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands., Nienhuis HLA; Department of Internal Medicine, Groningen Amyloidosis Center of Expertise, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Dec; Vol. 52 (1), pp. 88-97. Date of Electronic Publication: 2024 Aug 08.